RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire-AsiaNet/ Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model, adding to prior data demonstrating potent inhibition of all COVID-19 variants tested to date Opaganib's unique, host-targeted, dua...
Authors: LATEST ASIANET NEWS RELEASES